Encompass Health Reports Impressive Q4 2025 Results
Encompass Health Corporation (NYSE: EHC), recognized as the leading owner and operator of inpatient rehabilitation hospitals in the United States, has presented its operations results for the fourth quarter that concluded on December 31, 2025. The data reflects a remarkable performance throughout the year, showcasing the company's ability to adapt and grow within the healthcare landscape.
Summary of Financial Performance
The fourth quarter results reveal substantial increases in key financial metrics. In net operating revenue, the company reported $1,544.6 million, marking a growth of 9.9% compared to the previous year. This significant increase can be attributed to the higher patient volumes and improved services offered.
Key Financial Highlights of Q4 2025
- **Net Operating Revenue**: $1,544.6 million
- **Adjusted EBITDA**: $335.6 million
- **Earnings Per Share**: $1.42
- **Income from Continuing Operations**: $202.3 million
Growth and Strategic Initiatives
Mark Tarr, the President and CEO, expressed confidence in the company’s performance and future direction, stating, "Our Q4 performance was very strong, capping a stellar 2025. Our revenue increased by 10.5% with adjusted EBITDA growing by 14.9%. We are committed to expanding our capacity, as evidenced by the addition of 517 inpatient rehabilitation beds through eight new hospitals and the expansion of existing facilities."
These strategic expansions indicate Encompass Health's dedication to addressing the rising demand for rehabilitative services as the U.S. population ages. The company remains well-positioned to deliver high-quality care while enhancing operational efficiency.
Guidance for 2026
Looking ahead, Encompass Health has provided guidance for 2026 reflecting ongoing optimism and strategic planning. The anticipated financial outlook is grounded in established growth patterns:
- **Net Operating Revenue**: Expected within the range of $6,365 to $6,465 million
- **Adjusted EBITDA**: Forecasted between $1,340 to $1,380 million
- **Adjusted Earnings Per Share**: Projected between $5.81 to $6.10
Investor Engagement Activities
The company plans to host an investor conference call to discuss its Q4 2025 results. This session will offer insights into company performance and future strategies. Interested stakeholders can connect on February 6, 2026, at 10:00 a.m. Eastern Time by dialing in to the provided conference line.
About Encompass Health
Encompass Health operates a vast network of 173 inpatient rehabilitation hospitals across 39 states and Puerto Rico. The organization is dedicated to providing superior rehabilitative care, leveraging advanced technology and innovative practices to ensure optimal recovery for patients with significant injuries or illnesses.
Renowned for its compassionate service, Encompass Health has gained accolades as America's Most Awarded Leader in Inpatient Rehabilitation. Furthermore, it consistently ranks among Fortune's World's Most Admired Companies and Forbes' America's Best Companies.
Frequently Asked Questions
What financial metrics did Encompass Health report for Q4 2025?
Encompass Health reported net operating revenue of $1,544.6 million and adjusted EBITDA of $335.6 million for Q4 2025.
What is the outlook for Encompass Health in 2026?
The company expects net operating revenue between $6,365 to $6,465 million, with adjusted earnings per share projected between $5.81 to $6.10.
How many inpatient rehabilitation beds did Encompass Health add in 2025?
In 2025, Encompass Health added a total of 517 inpatient rehabilitation beds through the development of eight new hospitals and the expansion of existing facilities.
When will the investor conference call take place?
The investor conference call will be held on February 6, 2026, at 10:00 a.m. Eastern Time.
Where can I learn more about Encompass Health?
For additional information, visit Encompass Health's official website or follow them on social media platforms for the latest updates.
